Tirzepatide peptide, as an innovative achievement in the pharmaceutical field, is gradually emerging and bringing new hope to many people troubled by health problems. It is a drug carefully developed by Eli Lilly and Company. Its main active ingredient, tirzepatide, is a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor.
I. Core Mechanism of Action
1. Appetite Regulation: By activating the GLP-1 receptor, it acts on the satiety center in the hypothalamus, effectively reducing appetite and enhancing the feeling of fullness, thus reducing food intake. Many users have reported that after using tirzepatide peptide, their cravings for food significantly decreased. They no longer felt hungry as easily as before and could control their food intake more effortlessly.
2. Blood Glucose Regulation: It activates both GIP and GLP-1 receptors simultaneously, promoting insulin secretion and inhibiting glucagon release, thereby effectively controlling blood glucose levels. It also increases the sensitivity of pancreatic beta cells to glucose, further enhancing insulin synthesis and release, enabling blood glucose to remain within a relatively stable range. This is crucial for patients with type 2 diabetes, helping to reduce the various health risks associated with blood glucose fluctuations.
3. Optimization of Fat Metabolism: The activation of the GIP receptor enhances the uptake and utilization of glucose by adipose tissue, promotes energy consumption, and improves fat metabolism while inhibiting fat synthesis. The combined action of the two receptors promotes fat breakdown and metabolism, thus achieving weight loss. In clinical studies and practical applications, many obese patients have significantly reduced their body fat content and gradually lost weight after using tirzepatide peptide.
II. Applicable Areas
1. Treatment of Type 2 Diabetes: For adult patients with type 2 diabetes whose blood glucose control remains suboptimal despite diet control, exercise, and treatment with metformin and/or sulfonylureas, tirzepatide peptide is an effective treatment option. It can significantly reduce the glycated hemoglobin (HbA1c) level in patients, with a reduction exceeding 2.0%, outperforming most existing hypoglycemic drugs. It can also significantly increase the time blood glucose stays within the "normal range" and reduce the amplitude of blood glucose fluctuations, helping patients better control blood glucose and reducing the risk of diabetes complications.
2. Obesity and Overweight Management: It is suitable for patients with a body mass index (BMI) ≥ 30 kg/m²; patients with a BMI ≥ 27 kg/m² accompanied by at least one weight-related complication (such as type 2 diabetes, hypertension, hyperlipidemia, sleep apnea syndrome, etc.); and patients who have not responded to lifestyle interventions (such as diet control and exercise). In multiple clinical trials, tirzepatide peptide has demonstrated significant weight loss effects. For example, in the SURMOUNT - 1 trial, the average weight loss in the 15mg tirzepatide peptide group reached 22.5%. Compared with other weight loss drugs, tirzepatide peptide has a greater advantage in weight loss.
3. Potential Cardiovascular Protection: Some studies suggest that tirzepatide peptide may have a protective effect on the cardiovascular system through multiple mechanisms, such as reducing blood glucose, losing weight, and improving vascular endothelial function, reducing the risk of heart events and strokes, and improving the survival rate of patients with cardiovascular diseases. However, more clinical studies are needed to further confirm this.
III. Usage Instructions
1. Route of Administration: It is administered via subcutaneous injection once a week. Injections can be given in the abdomen, thigh, or upper arm. It can be administered at any time of the day, regardless of meals, which is convenient and greatly improves patient compliance.
2. Dose Adjustment: The recommended starting dose is 2.5mg, administered once a week. After 4 weeks of administration, the dose can be increased to 5mg. Subsequently, if further enhancement of blood glucose control or weight loss is required, the dosage should be adjusted under the strict guidance of a professional physician or pharmacist. Do not adjust the dose casually on your own to avoid affecting the treatment effect or causing adverse reactions.
IV. Safety and Precautions
1. Common Adverse Reactions: The adverse reactions that may occur during use mainly include gastrointestinal reactions, such as nausea, diarrhea, and constipation. However, most of these reactions are mild to moderate and tend to gradually subside over time. For example, some patients may experience mild nausea at the beginning of using tirzepatide peptide, but this symptom will significantly reduce after continuous use for a period of time.
2. Risk of Serious Adverse Reactions: Although rare, it is still necessary to be vigilant about the occurrence of serious adverse reactions such as severe allergic reactions (e.g., anaphylaxis, angioedema), acute kidney injury, and pancreatitis. Before taking the drug, patients should inform the doctor in detail about their allergic history, medical history, and other information so that the doctor can assess the risk of taking the drug.
3. Contraindicated Populations: Patients who are allergic to tirzepatide or any of its components; patients with a personal or family history of medullary thyroid carcinoma (MTC); patients with multiple endocrine neoplasia syndrome type 2 (MEN 2); patients with severe gastrointestinal diseases (such as severe gastroparesis); pregnant or breastfeeding women are prohibited from using it. Before using tirzepatide peptide, a comprehensive physical examination and assessment must be carried out, and it should be used under the guidance of professional medical staff to ensure the safety and effectiveness of the drug.
Our company is a modern advanced enterprise specializing in production and exportation of APIs, Pharmaceutical intermediates, plant extracts etc. Our products are widely used in medicine, health care products, cosmetics, nutritional supplements and food additives areas. Our factory covers an area of 95 acres, the proposed construction of the plant will be GMP standards, the factory environment clean and tidy, rational layout, with large and medium-sized production workshop and repocessed shop. It is equipped with advanced equipment quality inspection and research center. Those products of both quality and technical content have reached the domestic advanced level. Since its establishment, the company has attached great importance to the team training and technical reform. Our modern production equipment guarantees for a fast and effective production with a superior degree of accuracy throughout the whole production line, everything is done in-house, processing, extraction, packaging and transportation of all links, ensuring maximum quality and efficiency. We are constantly research and development new ingredients and innovative new products, have earned the respect & Admiration from the worldwide customers. After years of continuous development, company has been accumulated rich experience in international trade and customer resources, established a stable customer base and perfect marketing service network. In addition, the company has established long-term technical cooperation with experts and professors from many universities and research institutes in the province.
United States
Germany
Kenya
